The Global Fluorochemicals Market was estimated at USD 22.77 billion in 2019 and is projected to reach USD 34.96 billion by 2028, growing at a CAGR of 4.9% during the forecast period. Increasing HVAC systems installed in the manufacturing and automotive sectors are expected to propel this market during the forecast period.
Get free sample copy of this report @ https://bit.ly/3yYPnSA
Key Developments:
- In June 2010, 3M announced plans to adopt a new non-toxic perfluorooctane-sulfonyl fluoride technology to develop new products. These chemicals can be used as oil and water repellent coatings. New product developments, along with the expansion of production in manufacturing units located in or near high demand regions, are expected to remain critical success factors for growth.
- In 2015, refrigerants manufacturer SRF Ltd said on Thursday that it has agreed to purchase the global pharmaceutical propellant business from US chemicals maker DuPont. SRF is the only manufacturer of the pharma propellant known as HFC 134a in India using its indigenous technology. This transaction provides SRF immediate access to DuPont’s technology, brand and customers, thus enabling an instant entry into the niche pharmaceutical segment at a global level.
Market Segmentation:
By Product Type:
- Fluorocarbons
- Fluoropolymers
- Fluoroelastomers
- AlF3
- Others
By Application:
- Refrigerants
- Aluminum Production
- Plastic Foams
- Electrical Equipments
Companies Covered: Major Companies profiled in the report which are key players in the global fluorochemicals market DuPont, Arkema SA, 3M, Solvay SA, Daikin Honeywell, Asahi Glass, and Dongyue...
Get free PDF of this report @ https://bit.ly/2X8mSVi
The Global Asthma and COPD Drugs Market is expected to reach USD 62.32 billion by 2028 from USD 43.19 billion in 2019, growing at a CAGR of 4.2% during the forecast period.
Increasing asthma and COPD incidence and prevalence, advances in technology, and the rising senescent population is expected to propel the asthma and COPD drugs market during the forecast period.Get free sample copy of this report @ https://bit.ly/3m3lbRH Key Developments in the Asthma and COPD Drugs Market:In 2016, GlaxoSmithKline bought global rights to an experimental drug from Johnson and Johnson, raising its bet on a new generation of biotech medicines for severe asthma.
The British drugmaker launched Nucala, its first injectable biological asthma drug, and is looking for additional treatments to help more patients who are still struggling with breathing problems.In 2018, AstraZeneca unloaded rights to Alvesco (ciclesonide) to treat persistent asthma, and Omnaris and Zetonna (ciclesonide) to treat nasal symptoms associated with rhinitis.
The company indicates that the rights cover markets outside the United States and the US royalties for the drugs.
Covis already commercializes the three drugs in the US, but upon closing, it will own them.In 2015, AstraZeneca announced that it has entered into a definitive agreement to acquire the core respiratory business of Takeda Pharmaceutical Company Limited (“Takeda”).
The deal will include the expansion of rights to roflumilast (marketed as Daliresp in the US and Texas in other countries), the only approved oral PDE4 inhibitor for the treatment of chronic obstructive pulmonary disease (COPD).
The Global Intravenous Immunoglobulins Market to gain from rapid technological advancements taking place in the market.
Recently Fortune Business Insights has published a report, titled Intravenous Immunoglobulins Market Size, Share and Global Trend By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593Top Key Players Covered:Key players are involved in mergers and acquisition to strengthen their market position.
Owing to increasing competition frequent innovations are taking place in the global Intravenous Immunoglobulins market.
Some of the companies operating the global Intravenous Immunoglobulins market are;CSL BehringGrifols, S.A.Kedrion S.p.AOctapharmaBio Products Laboratory Ltd.Biotest AGChina Biologic Products Holdings, Inc.LFB SA and Shanghai RAAS Blood Products Co., Ltd.Rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Intravenous Immunoglobulins market.
Additionally, increasing per capita income and rising living standards is expected to drive the global Intravenous Immunoglobulins market during the forecast period 2018-2025.However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Intravenous Immunoglobulins market.As stated in the report North America holds a significant share in the market.
The trend is unlikely to change and North America may continue holding its position.
The Global Chinese Style Candle Holders Market report for the forecast period of 2017 – 2023 by MI Reports is a key insight into the Chinese Style Candle Holders across various parameters.
The solid research on the Chinese Style Candle Holders is prepared with the aim to meet the requirements of the customer in terms of the availability of data, analytics, statistics, and an accurate forecast of the Chinese Style Candle Holders.
Get a Free Pdf sample of this report at http://orbisresearch.com/contacts/request-sample/2063846 .
This can help the customer relate to the market and gain requisite insights into the Chinese Style Candle Holders for better understanding and planning.
It is necessary to understand all the drivers and restraints one might face in the market to plan the growth campaign effectively and realize substantial benefits.
The regions covered in this Global Chinese Style Candle Holders Market report include:
Growth in this market is driven by the growing pharmaceutical industry in Latin American countries such as Brazil, Mexico, and Argentina; increasing focus of MNCs on investing in the pharmaceutical and healthcare sectors in Latin America; growing pricing pressures; rapid growth in aging population & the subsequent increase in the prevalence of related diseases; and the availability of local and government funding for R activities.The report Latin America Pharmaceutical Excipients Market is projected to reach USD 579 million by 2024 from USD 403 million in 2019, at a CAGR of 7.5%.Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=41302221By functionality, the filler & diluents segment accounted for the largest share of the Latin America pharmaceutical excipients marketThe Latin America pharmaceutical excipients market, by functionality, is segmented into fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifiers & solubilizers, and other functionalities.
The fillers & diluents segment accounted for the largest market share in 2018.
The increased use of fillers & diluents in the development and production of solid dosage form and the wide applications of diluents in the wet granulation and direct compression process for tablet formulation are driving the growth of the fillers & diluents segment.Mexico to dominate the Latin America pharmaceutical excipients market during the forecast periodIn 2018, Mexico dominated the Latin America pharmaceutical excipients market, followed by Argentina.
Over the past few years, Mexico has become an attractive destination for investment in the pharmaceutical industry due to its large pharmaceutical production and consumption capacity and the improved regulatory framework.
Growing pharmaceutical production and consumption, increasing investments by MNCs, and improved regulatory framework are the major factors driving the growth of the pharmaceutical excipients market in Mexico.Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=41302221Top key Players: -Prominent players in the Latin America pharmaceutical excipients market are DowDuPont (US), Roquette (France), Ashland (US), BASF (Germany), and Kerry Group (Ireland).
The report "Medical Connectors Market by Product (Flat Silicone, Hybrid, Embedded, Radio Frequency, Push-Pull), Application (Patient Monitoring, Electrosurgery, Endoscopy, Diagnostic Imaging, Respiratory, Dental Device) & by End User - Global Forecast to 2021", report provides a detailed overview of the major drivers, restraints, trends, opportunities, and strategies impacting the medical connectors market along with the estimates and forecasts of the revenue and market share analysis.Browse 65 market data tables and 42 figures spread through 132 pages and in-depth TOC on "Medical Connectors Market by Product (Flat Silicone, Hybrid, Embedded, Radio Frequency, Push-Pull), Application (Patient Monitoring, Electrosurgery, Endoscopy, Diagnostic Imaging, Respiratory, Dental Device) & by End User - Global Forecast to 2021"Get Free PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81731061The medical connectors market is projected to reach USD 2.69 Billion by 2021 from USD 1.63 Billion in 2016, at a CAGR of 10.5%.
The major factors driving the growth of this market are increasing incidence and prevalence of chronic diseases, rapid growth in the medical devices market, and growth in the home healthcare market, which results in increased adoption of miniaturized connectors and growing healthcare expenditure across the globe.The medical connectors market is segmented based on products, application, end user, and region in this report.
On the basis of products, the market is segmented into flat surgical silicone cables, embedded electronics connectors, radio-frequency connectors, disposable plastic connectors, hybrid circular connectors & receptacle system, power cords with retention system, lighted hospital-grade cords, magnetic medical connectors, and push-pull connectors.
The flat surgical silicone cables segment is expected to grow at the highest CAGR during the forecast period.
Increasing awareness about the application of connectors and its technical features are the factors driving the growth of this segment.The market is classified into cardiology devices, diagnostic imaging devices, electrosurgical instruments, patient monitoring devices, endoscopy devices, respiratory devices, analyzers and processing instruments, dental instruments, neurology devices, enteral devices, and other applications.
The patient monitoring devices segment is expected to grow at the highest CAGR during the forecast period due to increasing incidence of chronic diseases and increasing adoption of patient monitoring devices.Know more about Medical Connectors Market - https://www.marketsandmarkets.com/PressReleases/medical-connector.asp
Hepatitis Test Solution/Diagnosis Market Analysis By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology, Trends, End-Users, Key Players, Trends and Insights Forecast To 2023
Pune, India – July 12, 2019 —
The global Hepatitis Test Solution/Diagnosis Market share to witness CAGR of 4.9% during the forecast period (2018-2023), Market Research Future (MRFR) reveals.
The global hepatitis test solution and diagnosis market could expect strong growth in the subsequent years as a result of the surge in cases of viral hepatitis as well as autoimmune diseases Increasing healthcare spending is another critical factor that could work in favor of the market in the near future.
Hepatitis Test Solution/Diagnosis Market Segmentation
The global market of hepatitis test solution/diagnosis has been segmented by
